Paternal tyrosine kinase inhibitor exposure and pregnancy outcomes

Researchers affiliated with the Hamad Medical Corporation in Doha (Qatar) have published a small case series examining the impact of tyrosine kinase inhibitors on fatherhood in patients with chronic myeloid leukemia (CML). More information can be found here.

Photo by Derek Thomson on Unsplash